AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
The potential of monoclonal antibodies to reduce reperfusion injury in myocardial infarction
Authors: McKenzie, ME Gurbel, PA
Citation: Me. Mckenzie et Pa. Gurbel, The potential of monoclonal antibodies to reduce reperfusion injury in myocardial infarction, BIODRUGS, 15(6), 2001, pp. 395-404
Platelet inhibition by sertraline and N-desmethylsertraline: A possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors
Authors: Serebruany, VL Gurbel, PA O Connor, CM
Citation: Vl. Serebruany et al., Platelet inhibition by sertraline and N-desmethylsertraline: A possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors, PHARMAC RES, 43(5), 2001, pp. 453-461
Usefulness of combining necrosis and platelet markers in triaging patientspresenting with chest pain to the emergency department
Authors: Serebruany, VL Levine, DJ Nair, GV Meister, AF Gurbel, PA
Citation: Vl. Serebruany et al., Usefulness of combining necrosis and platelet markers in triaging patientspresenting with chest pain to the emergency department, J THROMB TH, 11(2), 2001, pp. 155-162
Heparin prevents Xylum Clot Signature Analyser to detect platelet inhibition with clopidogrel during coronary stenting
Authors: Serebruany, VL Malinin, AI Bell, CR Gurbel, PA
Citation: Vl. Serebruany et al., Heparin prevents Xylum Clot Signature Analyser to detect platelet inhibition with clopidogrel during coronary stenting, THROMB RES, 102(1), 2001, pp. 95-97
Clinical utility of the platelet function analyzer (PFA-100) for the assessment of the platelet status in patients with congestive heart failure (EPCOT trial)
Authors: Serebruany, VL Alford, AB Meister, AF Fuzaylov, SY Gattis, WA Gurbel, PA O'Connor, CM
Citation: Vl. Serebruany et al., Clinical utility of the platelet function analyzer (PFA-100) for the assessment of the platelet status in patients with congestive heart failure (EPCOT trial), THROMB RES, 101(6), 2001, pp. 427-433
Platelet function and total length of intracoronary stents: Is there a correlation?
Authors: Cummings, CC McKenzie, ME Horowitz, ED Oshrine, BR Callahan, KP Gurbel, PA Serebruany, VL
Citation: Cc. Cummings et al., Platelet function and total length of intracoronary stents: Is there a correlation?, THROMB RES, 101(2), 2001, pp. 105-107
Statins do not affect platelet inhibition with clopidogrel during coronarystenting
Authors: Serebruany, VL Malinin, AI Callahan, KP Gurbel, PA Steinhubl, SR
Citation: Vl. Serebruany et al., Statins do not affect platelet inhibition with clopidogrel during coronarystenting, ATHEROSCLER, 159(1), 2001, pp. 239-241
Platelet function and fibrinolytic agents: Two sides of a coin?
Authors: Callahan, KP Malinin, AI Gurbel, PA Alexander, JH Granger, CB Serebruany, VL
Citation: Kp. Callahan et al., Platelet function and fibrinolytic agents: Two sides of a coin?, CARDIOLOGY, 95(2), 2001, pp. 55-60
Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy
Authors: Gurbel, PA O'Connor, CM Dalesandro, MR
Citation: Pa. Gurbel et al., Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy, AM J CARD, 87(6), 2001, pp. 774
Effect of selective serotonin reuptake inhibitors on platelets in patientswith coronary artery disease
Authors: Serebruany, VL O'Connor, CM Gurbel, PA
Citation: Vl. Serebruany et al., Effect of selective serotonin reuptake inhibitors on platelets in patientswith coronary artery disease, AM J CARD, 87(12), 2001, pp. 1398-1400
Uniform platelet activation exists before coronary stent implantation despite aspirin therapy
Authors: Serebruany, VL Cummings, CC Malinin, AI Steinhubl, SR Gurbel, PA
Citation: Vl. Serebruany et al., Uniform platelet activation exists before coronary stent implantation despite aspirin therapy, AM HEART J, 142(4), 2001, pp. 611-616
Baseline platelet aggregation and major receptor expression predict subsequent activity following thrombolysis for acute myocardial infarction
Authors: Gurbel, PA Kereiakes, DJ Atar, D Serebruany, VL
Citation: Pa. Gurbel et al., Baseline platelet aggregation and major receptor expression predict subsequent activity following thrombolysis for acute myocardial infarction, SC CARDIOVA, 34(1), 2000, pp. 53-58
Moderate alcohol consumption is associated with decreased platelet activity in patients presenting with acute myocardial infarction
Authors: Serebruany, VL Lowry, DR Fuzailov, SY Levine, DJ O'Connor, CM Gurbel, PA
Citation: Vl. Serebruany et al., Moderate alcohol consumption is associated with decreased platelet activity in patients presenting with acute myocardial infarction, J THROMB TH, 9(3), 2000, pp. 229-234
Oral platelet IIb/IIIa inhibitors: From attractive theory to clinical failures
Authors: Gurbel, PA Serebruany, VL
Citation: Pa. Gurbel et Vl. Serebruany, Oral platelet IIb/IIIa inhibitors: From attractive theory to clinical failures, J THROMB TH, 10(3), 2000, pp. 217-220
Effect of coronary thrombolysis on the plasma concentration of osteonectin(SPARC, BM40) in patients with acute myocardial infarction
Authors: Serebruany, VL Atar, D Murugesan, SR Jerome, S Semaan, H Gurbel, PA
Citation: Vl. Serebruany et al., Effect of coronary thrombolysis on the plasma concentration of osteonectin(SPARC, BM40) in patients with acute myocardial infarction, J THROMB TH, 10(2), 2000, pp. 197-202
Soluble P-selectin is not a surrogate marker for platelet P-selectin: Evidence from a Multicenter Chest Pain Study Group
Authors: Gurbel, PA Kereiakes, DJ Serebruany, VL
Citation: Pa. Gurbel et al., Soluble P-selectin is not a surrogate marker for platelet P-selectin: Evidence from a Multicenter Chest Pain Study Group, J THROMB TH, 10(1), 2000, pp. 15-22
Monitoring platelet inhibition during chronic oral platelet glycoprotein IIb/IIIa blockade: Are we missing something?
Authors: Serebruany, VL McKenzie, ME Levin, DJ Gurbel, PA
Citation: Vl. Serebruany et al., Monitoring platelet inhibition during chronic oral platelet glycoprotein IIb/IIIa blockade: Are we missing something?, THROMB HAEM, 83(2), 2000, pp. 356-357
Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge
Authors: Davis, CJ Gurbel, PA Gattis, WA Fuzaylov, SY Nair, GV O'Connor, SM Serebruany, VL
Citation: Cj. Davis et al., Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge, INT J CARD, 75(1), 2000, pp. 15-21
The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease
Authors: Semaan, HB Gurbel, PA Anderson, JL Muhlestein, JB Carlquist, JF Horne, BD Serebruany, VL
Citation: Hb. Semaan et al., The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease, J CARDIO PH, 36(4), 2000, pp. 533-537
Initial platelet activity may predict efficacy after chronic oral glycoprotein IIb/IIIa blockade: Should we still consider uniform treatment regimens?
Authors: Gurbel, PA McKenzie, ME Serebruany, VL
Citation: Pa. Gurbel et al., Initial platelet activity may predict efficacy after chronic oral glycoprotein IIb/IIIa blockade: Should we still consider uniform treatment regimens?, THROMB RES, 99(1), 2000, pp. 105-107
Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease
Authors: Semaan, HB Gurbel, PA Anderson, JL Muhlestein, JB Carlquist, JF Horne, BD Serebruany, VL
Citation: Hb. Semaan et al., Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease, CARDIOLOGY, 93(1-2), 2000, pp. 7-10
Combining necrosis and platelet markers for perfecting myocardial infarction rule out: How close are we?
Authors: Nair, GV Gurbel, PA Fuzaylov, SY Davis, CJ Ohman, EM Bahr, RD Christensen, RH Serebruany, VL
Citation: Gv. Nair et al., Combining necrosis and platelet markers for perfecting myocardial infarction rule out: How close are we?, CARDIOLOGY, 93(1-2), 2000, pp. 50-55
Depression and ischemic heart disease
Authors: O'Connor, CM Gurbel, PA Serebruany, VI
Citation: Cm. O'Connor et al., Depression and ischemic heart disease, AM HEART J, 140(4), 2000, pp. 563-569
Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department
Authors: Gurbel, PA Kereiakes, DJ Dalesandro, MR Bahr, RD O'Connor, CM Serebruany, VL
Citation: Pa. Gurbel et al., Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department, AM HEART J, 139(2), 2000, pp. 320-328
Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy
Authors: Serebruany, VL Murugesan, SR Pothula, A Atar, D Lowry, DR O'Connor, CM Gurbel, PA
Citation: Vl. Serebruany et al., Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy, EUR J HE FA, 1(3), 1999, pp. 243-249
Risultati: 1-25 | 26-39